[ad_1] The US Food and Drug Administration (FDA) has approved a new single-dose treatment to prevent relapses of one of the most dominant types of malaria. The new drug, Krintafel, targets only …
Read More »[ad_1] The US Food and Drug Administration (FDA) has approved a new single-dose treatment to prevent relapses of one of the most dominant types of malaria. The new drug, Krintafel, targets only …
Read More »